Trial Profile
PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With Myeloma. A Pilot Phase II Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jun 2023
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary) ; Vinorelbine
- Indications Myeloma; Stem cell mobilisation
- Focus Therapeutic Use
- Acronyms PAV
- 24 Mar 2014 New trial record